Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Generation and characterization of mAb 61H9 against junctional adhesion molecule-a with potent antitumor activity

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

Generation and Characterisation of Rabbit Monoclonal Antibodies Against the Native Cell Surface Antigens of Embryonic Stem Cells.

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias.

Construction, Expression and Functional Analysis of Anti-B7-h4-scfv-ch3 Recombinant Antibody

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics

A Novel Anti-sTn Monoclonal Antibody 3P9 Inhibits Human Xenografted Colorectal Carcinomas

Preparation of Functional Anti-Human Syndecan-1 Monoclonal Antibody and Its Biological Characteristics

Construction and Characterization of a High-Affinity Humanized SM5-1 Monoclonal Antibody.

An active murine–human chimeric Fab antibody derived from Escherichia coli , potential therapy against over-expressing VEGFR2 solid tumors

Preparation and Identification of Monoclonal Antibody Against Annexini

Preparation and anti-tumor activity of mouse monoclonal antibody against human F1-F0 ATP synthase beta subunit

Preparation and Characterization of Monoclonal Antibody Against Human Malignant Lymphoma

[Preparation of Anti-Human Integrin Beta 3 Monoclonal Antibody and Study on Its Antitumor Activity].

Production and characterization of domain-specific monoclonal antibodies against human ECM1.

Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumors

High Efficiency Reconstitution of a Human–Mouse Chimeric Fab of CAb‐1 Antibody Specific to Human Colon Cancer